JAMVX | VMVAX | JAMVX / VMVAX | |
Total Expense Ratio | 0.68 | 0.07 | 971% |
Annual Report Gross Expense Ratio | 0.69 | 0.07 | 986% |
Fund Existence | 22 years | 14 years | - |
Gain YTD | -6.771 | -6.125 | 111% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 113M | 29.9B | 0% |
Annual Yield % from dividends | 0.96 | 2.33 | 41% |
Returns for 1 year | -6.27 | 0.38 | -1,658% |
Returns for 3 years | -4.44 | 2.95 | -151% |
Returns for 5 years | 40.76 | 69.33 | 59% |
Returns for 10 years | 1.30 | 67.26 | 2% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IFGL | 19.32 | -0.05 | -0.26% |
iShares International Dev Real Est ETF | |||
RINF | 32.17 | -0.16 | -0.48% |
ProShares Inflation Expectations | |||
REMX | 35.50 | -1.23 | -3.35% |
VanEck Rare Earth & Strat Mtls ETF | |||
IWC | 100.50 | -4.48 | -4.27% |
iShares Micro-Cap ETF | |||
ONEQ | 64.45 | -3.09 | -4.58% |
Fidelity Nasdaq Composite ETF |